MONOAMINE-OXIDASE INHIBITORS - SAFETY AND EFFICACY ISSUES

被引:20
作者
BROWN, CS [1 ]
BRYANT, SG [1 ]
机构
[1] UNIV TEXAS,MED BRANCH,DEPT PSYCHIAT & BEHAV SCI,GALVESTON,TX 77550
来源
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1988年 / 22卷 / 03期
关键词
D O I
10.1177/106002808802200311
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:232 / 235
页数:4
相关论文
共 23 条
[1]   HYPERTENSIVE INTERACTIONS BETWEEN MONOAMINE OXIDASE INHIBITORS AND FOODSTUFFS [J].
BLACKWELL, B ;
MARLEY, E ;
PRICE, J ;
TAYLOR, D .
BRITISH JOURNAL OF PSYCHIATRY, 1967, 113 (497) :349-+
[2]   FORMS OF ATYPICAL DEPRESSION AND THEIR RESPONSE TO ANTIDEPRESSANT DRUGS [J].
DAVIDSON, J ;
PELTON, S .
PSYCHIATRY RESEARCH, 1986, 17 (02) :87-95
[3]  
DAVIDSON JRT, 1981, J CLIN PSYCHIAT, V42, P395
[4]  
DAVIDSON JRT, 1982, ARCH GEN PSYCHIAT, V39, P527
[5]  
DUNBAR J, 1977, NUTRITION LIPIDS COR
[6]  
FOLKS DG, 1983, J CLIN PSYCHOPHARM, V3, P249
[7]   DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED-PATIENTS TO SOMATIC THERAPY [J].
GREENBLATT, M ;
WECHSLER, H ;
GROSSER, GH .
AMERICAN JOURNAL OF PSYCHIATRY, 1964, 120 (10) :935-&
[8]  
LIEBOWITZ MR, 1984, ARCH GEN PSYCHIAT, V41, P669
[9]  
MCCABE BJ, 1986, J AM DIET ASSOC, V86, P1059
[10]  
MCGRATH PJ, 1984, AM J PSYCHIAT, V141, P288